financetom
Business
financetom
/
Business
/
SpaceX's rise under Trump 2.0 is welcome, Asia's No.1 satellite company says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
SpaceX's rise under Trump 2.0 is welcome, Asia's No.1 satellite company says
Feb 5, 2025 11:17 PM

TOKYO (Reuters) - For Asia's biggest satellite company, SKY Perfect JSAT ( SKPJF ), the rise of Elon Musk's rocket and satellite internet giant SpaceX under the second Donald Trump U.S. presidency is not a headwind, its president said on Thursday.

The Japanese firm will most likely see deeper ties with SpaceX, President Eiichi Yonekura said, after it announced a $230 million investment in Planet Labs' low-Earth orbit observation satellite Pelican to expand its satellite imagery business.

"The rapid advancement of SpaceX is never a negative factor for our growth," Yonekura told an earnings briefing, citing high dependence on SpaceX rockets to lift its satellites into space.

Musk's closeness to Trump has influenced U.S. policies in a way that could benefit SpaceX, such as a greater focus for Mars missions. Sources have told Reuters that the Trump administration is likely to axe the National Space Council after SpaceX lobbying.

Including the launches of Japanese radar satellite startup iQPS, which JSAT owns a minority stake, "we are probably the biggest SpaceX customer in Asia ... and Planet's Pelicans basically use Falcon 9 for launches," Yonekura said.

JSAT operates 17 geosynchronous communication satellites, the largest number in Asia, and will venture into the low-orbit observation business by building a constellation of 10 Planet Pelicans in 2027.

It is aiming for 23 billion yen ($151 million) in sales from the satellite data businesses in fiscal year 2030, nearly sixfold from current levels, mainly from national security clients.

SpaceX has lowered the cost of rocket launches by developing the reusable Falcon 9 booster, which has delivered thousands of communication satellites to orbit for its internet service, Starlink.

Even if JSAT loses access to SpaceX boosters, it would work with long-standing European partner Arianespace or Japan's Mitsubishi Heavy Industries ( MHVYF ), whose H3 rocket will become cost-competitive in four to five years, he added.

($1 = 152.3500 yen)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Herc Completes Tender Offer for H&E, Deal Close Set for June 2
Herc Completes Tender Offer for H&E, Deal Close Set for June 2
May 30, 2025
09:01 AM EDT, 05/30/2025 (MT Newswires) -- Herc Holdings ( HRI ) said Friday its tender offer to acquire H&E Equipment Services ( HEES ) expired at one minute past 11:59 pm ET on Thursday. The company said that roughly 69% of H&E shares were tendered by the deadline and will be paid in cash and stock as previously outlined....
Summit Therapeutics' Closely-Watched Lung Cancer Study Of Ivonescimab Misses Overall Survival Endpoint
Summit Therapeutics' Closely-Watched Lung Cancer Study Of Ivonescimab Misses Overall Survival Endpoint
May 30, 2025
Summit Therapeutics Inc. ( SMMT ) released topline results on Friday from the Phase 3 HARMONi trial of ivonescimab plus platinum-doublet chemotherapy compared to placebo plus platinum-doublet chemotherapy for epidermal growth factor receptor (EGFR)-mutated, locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) who have progressed after treatment with a 3rd generation EGFR tyrosine kinase inhibitor (TKI). The trial met the...
Vivakor to Issue Special Dividend in Adapti Shares
Vivakor to Issue Special Dividend in Adapti Shares
May 30, 2025
09:05 AM EDT, 05/30/2025 (MT Newswires) -- Vivakor ( VIVK ) said Friday it plans to issue a special dividend of 0.0079 shares of Adapti per Vivakor ( VIVK ) share. Vivakor ( VIVK ), which currently holds at 13.5% stake in Adapti, said it will establish a record date for the dividend in the next couple of weeks. The...
Copyright 2023-2026 - www.financetom.com All Rights Reserved